Shire [NPE] filed suit against Roxane Laboratories over 13 patents related to abuse-resistant amphetamine prodrugs. 7/7, District of New Jersey, 2:2011cv03886.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
